Hepatocellular carcinoma (HCC) is one of the most common malignancies globally, and is
frequently associated with a poor prognosis. 5-methylcytosine (m 5 C) is a common …

N6-methyladenosine (m6A) is the most abundant mRNA modification in mammals and has
been implicated in various biological processes. However, its role in hepatocellular …

The current study aims to investigate the significance of N 6-methyladenosine (m6A)
methylation-related genes in the clinical prognosis of hepatocellular carcinoma (HCC) using …

Aim: The search for prognostic biomarkers and the construction of a prognostic risk model
for hepatocellular carcinoma (HCC) based on N7-methyladenosine (m7G) methylation …

Hepatocellular carcinoma (HCC) is the most common type of liver cancer and is extremely
harmful to human health. In recent years, N6‐methyladenosine (m6A) RNA methylation in …

Background Accumulated evidence highlights the significance of the crosstalk between
epigenetic and epitranscriptomic mechanisms, notably 5-methylcytosine (5mC) and N6 …

Hepatocellular carcinoma (HCC) ranks fourth in cancer-related mortality worldwide. N1-
methyladenosine (m1A), a methylation modification on RNA, is gaining attention for its role …

Abstract Introduction N6-methyladenosine (m6A), the most prominent mRNA modification,
plays a critical role in many physiological and pathological processes. However, the roles of …

Background N6-methyladenosine (m6A)-mediated ribonucleic acid (RNA) methylation is
considered to be the most significant and abundant epigenetic modification in eukaryotic …

RNA modification of m6A/m5C/m1A contributes to the occurrence and development of
cancer. Consequently, this study aimed to investigate the functions of m6A/m5C/m1A …